ArticleTranslational andrology and urology2025
Shared genetic architecture between anxiety, depression and erectile dysfunction: a genome-wide cross-trait analysis.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The epidemiological association between erectile dysfunction (ED) and anxiety/depression has been extensively studied; however, the underlying genetic mechanisms remain elusive. This study aimed to investigate the shared genetic architecture linking ED with depression and anxiety disorders, and to identify common risk loci, associated genes, and underlying genetic mechanisms. Methods: Based on a large-scale genome-wide association study (GWAS) summary-level, genetic overlaps were identified between two common mental health problems (anxiety and depression) and ED (223,805 participants). Depression-related phenotypes: depression (finngen_R12_F5_DEPRESSIO, 494,164 participants), major depression (ieu-b-102, 500,199 participants), mental health problemsever diagnosed by a professional: depression (ukb-d-20544_11, 117,782 participants), depression or dysthymia (finngen_R12_F5_DEPRESSION_DYSTHYMIA, 326,981 participants), psychotic depression (finngen_R12_F5_DEPRESSION_PSYCHOTIC, 257,015 participants), recurrent or chronic depression (F5_DEPRESSION_RECURRENT, 280,487 participants). Anxiety-related phenotypes: all anxiety disorders (finngen_R12_F5_ALLANXIOUS, 480,289 participants), anxious personality disorder (finngen_R12_F5_ANXPER, 487,194 participants), generalized anxiety disorder (finngen_R12_F5_GAD, 451,562 participants), mental health problems ever diagnosed by a professional: anxiety, nerves or generalized anxiety disorder (ukb-d-20544_15, 117,751 participants). Cross-trait pleiotropic analysis was conducted to pinpoint shared pleiotropic loci and genes. Additionally, functional annotation and tissue-specific analyses were executed to assess the influence of pleiotropic genes. Subsequently, Mendelian randomization methods were applied to explore causal associations. Results: Our study uncovered complex genetic and causal connections between anxiety, depression, and ED. We identified shared pleiotropic risk loci (16p13.3, 6q16.3, 6q25.1, 1p35.1, 8q22.1, and so on) and genes ( Conclusions: Our research demonstrates a shared genetic architecture between mental health problems (anxiety and depression) and ED, shedding light on potential underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.